Resultados de la búsqueda 241-250 of 6603 for supplement interactions

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Specialized radiation therapy that delivers a high dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue.

  2. Aceite de pescado - Mayo Clinic

    Fish oil. Natural Medicines. https://naturalmedicines.therapeuticresearch.com. Accessed Nov. 22, 2020. Omega-3 supplements: In depth. National Center for ...

  3. Nutrición y comida saludable Healthy diets - Mayo Clinic

    Office of Dietary Supplements. https://ods.od.nih.gov/factsheets/WYNTK-Consumer/ Accessed June 13, 2023. Vitamins, minerals and supplements: Do ...

  4. Hematología - Ensayos clínicos - Mayo Clinic

    Most newly-diagnosed CLL patients have early-stage disease at the time of diagnosis and do not require treatment. Despite not needing therapy, these patients ...

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic ...

  6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Specialized radiation therapy that delivers a high dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue.

  7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This phase Ib trial studies the side effects and best dose of a vaccine called H2NVAC before surgery in treating patients with HER2 expressing ductal carcinoma ...

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to evaluate the safety and effectiveness of CapsoCam® Colon (CV-3) endoscope system for the detection of colonic polyps.

  9. Cirugía - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to collect adipose tissue from patients undergoing elective surgery, or from healthy volunteers, test the donors to assure that ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...